Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle White

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
BMJ Global Health|December 12, 2017
Effect of removing the barrier of transportation costs on surgical utilisation in Guinea, Madagascar and the Republic of CongoMark G Shrime, Mirjam Hamer, Swagoto Mukhopadhyay, et al.
Molecular Immunology|December 3, 2014
The effect of the decoy molecule PA401 on CXCL8 levels in bronchoalveolar lavage fluid of patients with cystic fibrosisOliver J McElvaney, Niamh O'Reilly, Michelle White, et al.
Contemporary Clinical Trials|August 12, 2022
The Sleep, Cancer and Rest (SleepCaRe) Trial: Rationale and design of a randomized, controlled trial of cognitive behavioral and bright light therapy for insomnia and fatigue in women with breast cancer receiving chemotherapyJordan Maccora, Sheila N Garland, Maria Ftanou, et al.
Breast (Edinburgh, Scotland)|December 19, 2024
Evaluating the impact of a tertiary multidisciplinary meeting in metastatic breast cancer: A prospective studyBelinda Sassé, Sammy Shaya, Jessica Nimmo, et al.
Psycho-Oncology|March 22, 2026
A Randomized Controlled Trial: Evaluating the Sleep, Cancer and Rest (SleepCaRe) Trial to Improve Health-Related Quality of Life in Women Undergoing Chemotherapy for Breast CancerRebecca Wallace, Marliese Alexander, Daphne Day, et al.
The Lancet. Oncology|April 19, 2014
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trialFabrice André, Ruth O'Regan, Mustafa Ozguroglu, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|October 3, 2025
Evaluation of the Crosslinguistic Nonword Repetition Test: Evidence From a Large and Diverse Secondary Data SetKamila Polišenská, Shula Chiat, Jakub Szewczyk, et al.
Breast Cancer Research and Treatment|December 2, 2021
Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testingPhuong Dinh, J Dinny Graham, Elisabeth N Elder, et al.
NPJ Precision Oncology|September 5, 2019
Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBCNatasha K Brockwell, Jai Rautela, Katie L Owen, et al.
Endocrine-Related Cancer|September 1, 2025
Neoadjuvant palbociclib in women with operable, hormone receptor-positive breast cancerTakayuki Ueno, Louis W C Chow, Wonshik Han, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
BMJ Global Health|December 12, 2017
Effect of removing the barrier of transportation costs on surgical utilisation in Guinea, Madagascar and the Republic of CongoMark G Shrime, Mirjam Hamer, Swagoto Mukhopadhyay, et al.
Molecular Immunology|December 3, 2014
The effect of the decoy molecule PA401 on CXCL8 levels in bronchoalveolar lavage fluid of patients with cystic fibrosisOliver J McElvaney, Niamh O'Reilly, Michelle White, et al.
Contemporary Clinical Trials|August 12, 2022
The Sleep, Cancer and Rest (SleepCaRe) Trial: Rationale and design of a randomized, controlled trial of cognitive behavioral and bright light therapy for insomnia and fatigue in women with breast cancer receiving chemotherapyJordan Maccora, Sheila N Garland, Maria Ftanou, et al.
Breast (Edinburgh, Scotland)|December 19, 2024
Evaluating the impact of a tertiary multidisciplinary meeting in metastatic breast cancer: A prospective studyBelinda Sassé, Sammy Shaya, Jessica Nimmo, et al.
Psycho-Oncology|March 22, 2026
A Randomized Controlled Trial: Evaluating the Sleep, Cancer and Rest (SleepCaRe) Trial to Improve Health-Related Quality of Life in Women Undergoing Chemotherapy for Breast CancerRebecca Wallace, Marliese Alexander, Daphne Day, et al.
The Lancet. Oncology|April 19, 2014
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trialFabrice André, Ruth O'Regan, Mustafa Ozguroglu, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|October 3, 2025
Evaluation of the Crosslinguistic Nonword Repetition Test: Evidence From a Large and Diverse Secondary Data SetKamila Polišenská, Shula Chiat, Jakub Szewczyk, et al.
Breast Cancer Research and Treatment|December 2, 2021
Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testingPhuong Dinh, J Dinny Graham, Elisabeth N Elder, et al.
NPJ Precision Oncology|September 5, 2019
Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBCNatasha K Brockwell, Jai Rautela, Katie L Owen, et al.
Endocrine-Related Cancer|September 1, 2025
Neoadjuvant palbociclib in women with operable, hormone receptor-positive breast cancerTakayuki Ueno, Louis W C Chow, Wonshik Han, et al.
Pageof 8